PAIN
Volume 145, Issue 3 , Pages 304-311 , October 2009

Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1

  • Marnix J. Sigtermans

      Affiliations

    • Department of Anesthesiology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • These authors contributed equally to this work.
  • ,
  • Jacobus J. van Hilten

      Affiliations

    • Department of Neurology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • These authors contributed equally to this work.
  • ,
  • Martin C.R. Bauer

      Affiliations

    • Department of Anesthesiology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
  • ,
  • M. Sesmu Arbous

      Affiliations

    • Department of Intensive Care, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
  • ,
  • Johan Marinus

      Affiliations

    • Department of Neurology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
  • ,
  • Elise Y. Sarton

      Affiliations

    • Department of Anesthesiology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
  • ,
  • Albert Dahan

      Affiliations

    • Department of Anesthesiology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 71 526 2301; fax: +31 71 526 4824.

Received 1 April 2009 ,Revised 20 May 2009 ,Accepted 18 June 2009.

References 

  1. Albazaz R, Wong YT, Homer-Vanniasinkam S. Complex regional pain syndrome: a review. Ann Vasc Surg. 2008;22:297–306
  2. Bell R, Eccleston C, Kalso E. Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev 2003: CD003351.
  3. Brazier JE, Harper R, Jones NM, O’Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305:160–164
  4. Bruehl S, Harden RN, Galer BS, Saltz S, Bertram M, Backonja M, et al. External validation of IASP diagnostic criteria for complex regional pain syndrome and proposed research diagnostic criteria. International Association for the Study of Pain. Pain. 1999;81:147–154
  5. Correll GE, Maleki J, Gracely EJ, Muir JJ, Harbut RE. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. Pain Med. 2004;5:263–275
  6. De Mos M, De Bruijn AG, Huygen FJ, Dieleman JP, Stricker BH, Sturkenboom MC. The incidence of complex regional pain syndrome: a population-based study. Pain. 2007;129:12–20
  7. Galer BS, Henderson J, Perander J. Jensen MP: course of symptoms and quality of life measurement in complex regional pain syndrome: a pilot survey. J Pain Symptom Manage. 2000;20:286–292
  8. Geha PY, Baliki MN, Herden RN, Bauer WR, Parrish TB, Apkarian AV. The brain in chronic CRPS pain: abnormal gray-white matter interactions in emotional and autonomie regions. Neuron. 2008;60:570–581
  9. Goldberg ME, Domsky R, Scaringe D, Hirsch R, Dotson J, Sharaf I, et al. Multi-day low dose ketamine infusion for treatment of complex regional pain syndrome. Pain Phys. 2005;8:175–179
  10. Himmelseher S, Durieux ME. Revising a dogma: ketamine for patients with neurological injury?. Anesth Analg. 2005;101:524–534
  11. Juottonen K, Gockel M, Silén T, Hurri H, Hari R, Forss N. Altered central sensorimotor processing in patients with complex regional pain syndrome. Pain. 2002;98:315–323
  12. Kemler MA, Barendse GAM, van Kleef M, de Vet HCW, Rijks CPM, Furnée CA, et al. Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. N Engl J Med. 2000;343:618–624
  13. Kemler MA, De Vet HC. Health-related quality of life in chronic refractory reflex sympathetic dystrophy (complex regional pain syndrome type I). J Pain Symptom Manage. 2000;20:68–76
  14. Khan SA, Apkarian AV. The characteristics of cyclical and non-cyclical mastalgia: a prospective study using a modified McGill Pain Questionnaire. Breast Cancer Res Treat. 2002;75:147–157
  15. Kiefer R-T, Rohr P, Ploppa A, Altemeyer K-H, Schwartzman RJ. Complete recovery from intractable complex regional pain syndrome, CRPS-type 1, following anesthetic ketamine and midazolam. Pain Pract. 2007;7:147–150
  16. Kiefer R-T, Rohr P, Ploppa A, Dieterich H-J, Grothisen J, Koffler S, et al. Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II study. Pain Med. 2008;9:1173–1201
  17. Kiefer RT, Rohr P, Ploppa A, Unertl K, Schwartzman RJ. Is high dosed ketamine a therapeutic option for severe intractable complex regional pain syndrome?. Anesthesiology. 2003;99:A1008
  18. Kiefer RT, Rohr P, Unertl K, Altmeyer KH, Grothusen J, Schwartzman RJ. Recovery from intractable complex regional pain syndrome type-I (RSD) under high dose intravenous ketamine–midazolam sedation. Neurology. 2002;58:A474
  19. Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc. 1968;16:622–626
  20. Maihöfner C, Handwerker HO, Neundörfer B, Birklein F. Patterns of cortical reorganization in complex regional pain syndrome. Neurology. 2003;61:17-7-15
  21. Maihöfner C, Handwerker HO, Neundörfer B, Birklein F. Cortical reorganization during recovery from complex regional pain syndrome. Neurology. 2004;63:693–701
  22. Mercadante S, Arcuri E, Tirelli W, Casuccio A. Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study. J Pain Symptom Manage. 2000;20:246–252
  23. Merskey H, Bogduk K. Classification of chronic pain: definitions of chronic pain syndromes and definition of pain terms. Seattle: IASP Press; 1994;
  24. Oerlemans HM, Cup EH, DeBoo T, Goris RJ, Oostendorp RA. The Radboud skills questionnaire: construction and reliability in patients with reflex sympathetic dystrophy of one upper extremity. Disabil Rehabil. 2000;22:233–245
  25. Oerlemans HM, Goris RJ, Oostendorp RA. Impairment level sumscore in reflex sympathetic dystrophy of one upper extremity. Arch Phys Med Rehabil. 1998;79:979–990
  26. Oerlemans HM, Oostendorp RA, de Boo T, Goris RJ. Pain and reduced mobility in complex regional pain syndrome I: outcome of a prospective randomised controlled clinical trial of adjuvant physical therapy versus occupational therapy. Pain. 1999;83:77–83
  27. Olney JW, Labruyere J, Wang G, Wozniak DF, Price MT, Sesma A. NMDA antagonist neurotoxicity: mechanisms and prevention. Science. 1991;254:1515–1518
  28. Perez RS, Oerlemans HM, Zuurmond WW, De Lange JJ. Impairment level sumscore for lower extremity complex regional pain syndrome type I. Disabil Rehabil. 2003;25:984–991
  29. Perez RS, Roorda LD, Zuurmond WW, Bannink II, Vranken JH, De Lange JJ. Measuring perceived activity limitations in lower extremity complex regional pain syndrome type 1 (CRPS I): test–retest reliability of two questionnaires. Clin Rehabil. 2002;16:454–460
  30. Perez RS, Zuurmond WW, Bezemer PD, Kuik DJ, van Loenen AC, De Lange JJ, et al. The treatment of complex regional pain syndrome type I with free radical scavengers: a randomized controlled study. Pain. 2003;102:297–307
  31. Pleger B, Ragert P, Schwenkreis P, Förster A-F, Wilimzig C, Dinse H, et al. Patterns of cortical reorganization parallel impaired tactile discrimination and pain intensity in complex regional pain syndrome. Neuroimage. 2006;32:503–510
  32. Pleger B, Tegenthoff M, Ragert P, Förtser AF, Dinse HR, Schwenkreis P, et al. Sensorimotor returning in complex regional pain syndrome parallels pain reduction. Ann Neurol. 2005;57:425–429
  33. Rommel O, Malin JP, Zenz M, Janig W. Quantitative sensory testing, neurophysiological and psychological examination in patients with complex regional pain syndrome and hemisensory deficits. Pain. 2001;93:279–293
  34. Sang CN. NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials. J Pain Symptom Manage. 2000;19:S21–S25
  35. Schwartzmann RJ. New treatments for reflex sympathetic dystrophy. N Engl J Med. 2000;343:654–656
  36. Schwartzman RJ, Grothusen J, Kiefer TR, Rohr P. Neuropathic central pain: epidemiology, etiology, and treatment options. Arch Neurol. 2001;58:1547–1550
  37. Schüttler J, Stanski DR, White PF, Trevor AJ, Horai Y, Verotta D. Sheiner LB: pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man. J Pharmacokinet Biopharm. 1987;15:241–253
  38. Shirani P, Salamone AR, Schulz PE, Edmondson EA. Ketamine treatment for intractable pain in a patient with severe refractory complex regional pain syndrome: a case report. Pain Phys. 2008;11:229–242
  39. Sigtermans MJ, Olofsen E, Sarton EY, Kleef van JW, Dahan A. PK/PD modeling of the analgesic and side effects of low-dose S(+)-ketamine in healthy volunteers. Anesthesiology 2008; ASA annual meeting, abstract #A1584.
  40. Stomp-van den BSG, Vlaeyen JW, van Breukelen G, Stomp SG, ter Kuile MM, Kole-Snijders AM. Meetinstrumenten chronische pijn: deel 2. Pijn Coping en Cognitielijst (PCCL). Pijn Kennis Centrum; 2001.
  41. Veldman PH, Reynen HM, Arntz IE, Goris RJ. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet. 1993;342:1012–1016
  42. Vlaeyen JW, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain. 2000;85:317–332
  43. Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, et al. A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63:856–864
  44. Zhou QQ, Imbe H, Zou S, Dubner R, Ren K. Selective upregulation of the flip-flop splice variants of AMPA receptor subunits in the rat spinal cord after hindpaw inflammation. Brain Res Mol Brain Res. 2001;88:186–193
  45. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–370

PII: S0304-3959(09)00368-6

doi: 10.1016/j.pain.2009.06.023

PAIN
Volume 145, Issue 3 , Pages 304-311 , October 2009